Journal of Qualitative Research in Health Sciences

Document Type : Original Article


1 Department of Medical Oncology and Hematology, Iran University of Medical Sciences, Tehran, Iran

2 Department of the Cancer Palliative Care, Deputy of Health, Ministry of Health and Medical Education, Tehran, Iran

3 Department of Home-Based Palliative Care, Iranian Cancer Control Center, Tehran, Iran

4 Social Determinants of Health Research Center, School of Nursing and Midwifery, Lorestan University of Medical Sciences, Khorramabad, Iran

5 French Institute of Research and High Education (IFRES-INT), Paris, France

6 Student Research Committee, Iran University of Medical Sciences, Tehran, Iran



Background: Patients with cancer are among the groups that are vulnerable to the COVID-19 crisis. Identifying the factors affecting the process of healthcare provision can improve the health services provided to cancer patients. Therefore, this study aimed to explain stakeholders’ perception of the healthcare services provided to cancer patients during the COVID-19 pandemic.
Methods: The present qualitative study was conducted using the conventional content analysis method in Iran in 2021. Participants included cancer patients, their families, and healthcare providers, who were selected via purposive sampling. Data were collected through 19 individual interviews and two focus groups and then analyzed using the method proposed by Graneheim and Lundman.
Results: Qualitative data analysis revealed seven main categories, including the disruption of care continuity, reduced quality of health services, poor provision of community-based services, lack of comprehensive care, lack of public education, predicting changes in cancer incidence and mortality trends, and ethical challenges.
Conclusion: The COVID-19 pandemic has exposed cancer patients to many challenges, including limited access to health services. Therefore, there is a need to facilitate these patients’ access to safe healthcare services.


Vahid Kaveh (Google Scholar) (PubMed)

Pooneh Pirjani (Google Scholar) (PubMed)

Heshmatolah Heydari (Google Scholar) (PubMed)

Kosar Sadat Hosseini Kolbadi (Google Scholar) (PubMed)

Ghazal Razani (Google Scholar) (PubMed)

Romina Sadeqian (Google Scholar) (PubMed)

Mehdi Ashouri (Google Scholar) (PubMed)

Mandana Saki (Google Scholar) (PubMed)

Suzanne Hojjat-Assari (Google Scholar) (PubMed)


  1. WHO Announces COVID-19 Outbreak a Pandemic. CDC. Available from: Accessed March 3, 2020.
  2. Timeline: Coronavirus Epidemic. Available from: Accessed March 3, 2020.
  3. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7. doi: 1016/s1470-2045(20)30096-6.
  4. Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21(4):e181. doi: 1016/s1470-2045(20)30149-2.
  5. Sica A, Massarotti M. Myeloid suppressor cells in cancer and autoimmunity. J Autoimmun. 2017;85:117-25. doi: 1016/j.jaut.2017.07.010.
  6. Garassino MC, Whisenant JG, Huang LC, Trama A, Torri V, Agustoni F, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21(7):914-22. doi: 1016/s1470-2045(20)30314-4.
  7. Non-Communicable Disease Report in Iran. Available from: = 1. Accessed July 19, 2021.
  8. Toulabi T, Jafari Pour F, Veiskramian A, Heydari H. Exploring COVID-19 patients’ experiences of psychological distress during the disease course: a qualitative study. BMC Psychiatry. 2021;21(1):625. doi: 1186/s12888-021-03626-z.
  9. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105-12. doi: 1016/j.nedt.2003.10.001.
  10. Lincoln YS, Guba EG. Naturalistic Inquiry. Sage Publications; 1985.
  11. Rezapour Nasrabad R. Criteria of validity and reliability in qualitative research. J Qual Res Health Sci. 2018;6(4):493-9. [Persian].
  12. Chia JMX, Goh ZZS, Chua ZY, Ng KYY, Ishak D, Fung SM, et al. Managing cancer in context of pandemic: a qualitative study to explore the emotional and behavioural responses of patients with cancer and their caregivers to COVID-19. BMJ Open. 2021;11(1):e041070. doi: 1136/bmjopen-2020-041070.
  13. Jazieh AR, Akbulut H, Curigliano G, Rogado A, Alsharm AA, Razis ED, et al. Impact of the COVID-19 pandemic on cancer care: a global collaborative study. JCO Glob Oncol. 2020;6:1428-38. doi: 1200/go.20.00351.
  14. Riera R, Bagattini  M, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A. Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review. JCO Glob Oncol. 2021;7:311-23. doi: 1200/go.20.00639.
  15. American Society of Hematology. COVID-19 Resources. Available from: Accessed April 28, 2020.
  16. Chen W, Su XY, Wang VJ, Wang EC, Xu R, Zhong S, et al. Novel coronavirus international public health emergency: guidance on radiation oncology facility operation. Adv Radiat Oncol. 2020;5(4):560-6. doi: 1016/j.adro.2020.03.008.
  17. Lesley GC, Tahmasebi H, Meti N, Wright FC, Thawer A, Cheung M, et al. Cancer treatment during COVID-19: a qualitative analysis of patient-perceived risks and experiences with virtual care. J Patient Exp. 2021;8:23743735211039328. doi: 1177/23743735211039328.
  18. Drury A, Eicher M, Dowling M. Experiences of cancer care during COVID-19: phase 1 results of a longitudinal qualitative study. Int J Nurs Stud Adv. 2021;3:100030. doi: 1016/j.ijnsa.2021.100030.
  19. Abu Esba LC, Al-Abdulkarim HA, Alrushidan A, Al Harbi M. Pharmacy and therapeutics committee preparedness plan for COVID-19. Glob J Qual Saf Healthc. 2020;3(2):55-64. doi: 36401/jqsh-20-9.
  20. Wise J. COVID-19: remdesivir is recommended for authorisation by European Medicines Agency. BMJ. 2020;369:m2610. doi: 1136/bmj.m2610.
  21. Barati O, Khammarnia M, Sadeghi A, Siavashi E. Skills, capabilities, and requirements of hospital managers: a qualitative study. J Qual Res Health Sci. 2020;5(1):17-28. [Persian].
  22. Garg AK. Community-based cancer care quality and expertise in a COVID-19 era and beyond. Am J Clin Oncol. 2020;43(8):537-8. doi: 1097/coc.0000000000000725.
  23. Kamran A, Isazadehfar K, Heydari H, Nasimi Doost Azgomi R, Naeim M. Risk perception and adherence to preventive behaviours related to the COVID-19 pandemic: a community-based study applying the health belief model. BJPsych Open. 2021;7(4):e133. doi: 1192/bjo.2021.954.
  24. Mishra S, Biswas S, Bhatnagar S. Palliative care delivery in cancer patients in the era of COVID-19 outbreak: unique needs, barriers, and tools for solutions. Indian J Palliat Care. 2020;26(Suppl 1):S130-S41. doi: 4103/ijpc.ijpc_194_20.
  25. Cinar P, Kubal T, Freifeld A, Mishra A, Shulman L, Bachman J, et al. Safety at the time of the COVID-19 pandemic: how to keep our oncology patients and healthcare workers safe. J Natl Compr Canc Netw. 2020;18(5):504-9. doi: 6004/jnccn.2020.7572.
  26. Hojjat-Assari S, Rassouli M, Madani M, Heydari H. Developing an integrated model of community-based palliative care into the primary health care (PHC) for terminally ill cancer patients in Iran. BMC Palliat Care. 2021;20(1):100. doi: 1186/s12904-021-00795-2.
  27. Gondal H, Choquette H, Abbas T, Le D, Chalchal HI, Iqbal N, et al. Patients and physicians’ satisfaction with telemedicine (TM) in cancer care and factors that correlate with a positive patient’s experience. Ann Oncol. 2019;30 Suppl 5:v730. doi: 1093/annonc/mdz265.037.
  28. Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020;295(3):200463. doi: 1148/radiol.2020200463.
  29. Remon J, Passiglia F, Ahn MJ, Barlesi F, Forde PM, Garon EB, et al. Immune checkpoint inhibitors in thoracic malignancies: review of the existing evidence by an IASLC expert panel and recommendations. J Thorac Oncol. 2020;15(6):914-47. doi: 1016/j.jtho.2020.03.006.
  30. Tsamakis K, Gavriatopoulou M, Schizas D, Stravodimou A, Mougkou A, Tsiptsios D, et al. Oncology during the COVID-19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients. Oncol Lett. 2020;20(1):441-7. doi: 3892/ol.2020.11599.
  31. Delaunay M, Prévot G, Collot S, Guilleminault L, Didier A, Mazières J. Management of pulmonary toxicity associated with immune checkpoint inhibitors. Eur Respir Rev. 2019;28(154):190012. doi: 1183/16000617.0012-2019.
  32. Sadeghi R, Mortaz Hejri S, Shakibazadeh E, Rahimi Foroushani A, Heshmati H. Barriers of health education in Iran’s health system: a qualitative study. J Qual Res Health Sci. 2020;8(3):300-17. [Persian].
  33. Solhi M, Khalili F, Irandoost SF, Hoseinian SK. Explaining the experiences of health care providers about barriers of client education in Ghaemshahr health centers: a qualitative study. J Qual Res Health Sci. 2020;8(2):120-30. [Persian].
  34. Saberi MK, Paknahad S, Jowkar A. Health literacy of patients with breast cancer: a qualitative study. J Qual Res Health Sci. 2020;8(2):131-42. [Persian].
  35. Malagón T, Yong JHE, Tope P, Miller WH, Jr., Franco EL. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada. Int J Cancer. 2022;150(8):1244-54. doi: 1002/ijc.33884.
  36. Liu C, Zhao Y, Okwan-Duodu D, Basho R, Cui X. COVID-19 in cancer patients: risk, clinical features, and management. Cancer Biol Med. 2020;17(3):519-27. doi: 20892/j.issn.2095-3941.2020.0289.
  37. Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783-91. doi: 1158/
  38. Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, et al. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol. 2020;31(8):1088-9. doi: 1016/j.annonc.2020.04.006.
  39. Yang L, Chai P, Yu J, Fan X. Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants. Cancer Biol Med. 2021;18(1):298-307. doi: 20892/j.issn.2095-3941.2020.0559.
  40. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: 3322/caac.21492.